Healthcare Technology
ABL Diagnostics is a molecular biology diagnostic company founded in 2015 that designs, develops, manufactures, and markets diagnostic tests for infectious diseases. The company specializes in proprietary molecular biology solutions including UltraGene® for detection and DeepChek® for genotyping by DNA sequencing. ABL Diagnostics has developed high-tech genotyping medical devices for chronic infectious diseases such as AIDS, viral hepatitis, tuberculosis, and SARS-CoV-2, along with other viral and bacterial targets. The company operates in France and internationally through a network of exclusive distributors across 45 countries.
Industry
Healthcare Technology
Company Size
51-200 employees
Founded
2015
Beta · Sourced from candidate reports
Be the first to share your experience with ABL.
Your reply helps other candidates know what to expect.
